108 Folgen

  1. Contemporary molecular prognostic signatures in glioma

    Vom: 30.8.2024
  2. FDG PET in PCNSL

    Vom: 9.8.2024
  3. TMZ and MGMT in elderly GBM patients

    Vom: 12.7.2024
  4. IDH mutant glioma and IDH inhibitors

    Vom: 5.7.2024
  5. Leptomeningeal disease, a SNO and ASCO review

    Vom: 28.6.2024
  6. Cancer stems cell in GBM

    Vom: 21.6.2024
  7. Drug delivery across the blood-brain barrier

    Vom: 13.6.2024
  8. Gliomatosis cerebri in children

    Vom: 24.5.2024
  9. Immunotherapy drives mesenchymal shift in GBM

    Vom: 17.5.2024
  10. Long-term outcomes of pediatric patients with optic pathway glioma

    Vom: 4.5.2024
  11. NF1 mutation and neuronal hyperexcitability

    Vom: 12.4.2024
  12. Postoperative cerebellar mutism

    Vom: 5.4.2024
  13. Cell cycle checkpoints and alkylating agents

    Vom: 22.3.2024
  14. Liquid biopsy in CNS lymphoma

    Vom: 15.3.2024
  15. Immunotherapy for glioblastoma, lessons learned

    Vom: 8.3.2024
  16. TERTp mutation clonality in glioma

    Vom: 27.2.2024
  17. Liquid biopsy in H3K27M glioma

    Vom: 9.2.2024
  18. Glioma genetic profiles and electrophysiologic hyperexcitability

    Vom: 26.1.2024
  19. Epidemiology of glioma in Belgium

    Vom: 12.1.2024
  20. The Biology of H3K27M Mutant Gliomas

    Vom: 23.12.2023

2 / 6

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site